Impact of red and processed meat and fibre intake on treatment outcomes among patients with chronic inflammatory diseases:protocol for a prospective cohort study of prognostic factors and personalised medicine

Autor: Mette Boye, Jimmi Wied, Andre Franke, Henning Glerup, Tue Bjerg Bennike, Jacob Broder Brodersen, Jakob Grauslund, Ivan Brandslund, Jan Fallingborg, Ulrich Fredberg, Robin Christensen, Nils J. Færgeman, Steffen Thiel, Mohamad Jawhara, Vibeke Andersen, Anders Bojesen, Anette Bygum, Jens Frederik Dahlerup, Grith Lykke Sørensen, Jesper Frøjk, Torkell Ellingsen, Erik Berg Schmidt, Lars Werner, Jan Alexander Villadsen, Ole Haagen Nielsen, Philip Rosenstiel, Berit L. Heitmann, Søren Geill Kjær, Signe Bek Sørensen, David Ellinghaus, Lone Hvid, Uffe Holmskov, Charlotte Lindgaard Nielsen, Heidi Lausten Munk, Jeroen Raes, Karina Winther Andersen, Torben Knudsen, Anders Bathum Nexøe, Jens Kjeldsen, Seyed A G R Moghadd, Allan Stensballe
Jazyk: angličtina
Rok vydání: 2018
Předmět:
Dietary Fiber
Disease
Inflammatory bowel disease
0302 clinical medicine
lifestyle and chronic inflammatory disease
Quality of life
Protocol
Hidradenitis suppurativa
Prospective Studies
030212 general & internal medicine
Precision Medicine
Prospective cohort study
Research Support
Non-U.S. Gov't

EUROPEAN PROSPECTIVE COHORT
ANKYLOSING-SPONDYLITIS
General Medicine
biomarker and lifestyle
personalized medicine
Prognosis
CROHNS-DISEASE
Medical Management
3. Good health
Meat Products
ULCERATIVE-COLITIS
SHORT HEALTH SCALE
Research Design
SULFATE-REDUCING BACTERIA
030211 gastroenterology & hepatology
medicine.medical_specialty
Skin Diseases
Uveitis
03 medical and health sciences
Psoriatic arthritis
patient related outcome measures
Rheumatic Diseases
Internal medicine
Psoriasis
medicine
Journal Article
Humans
Patient Reported Outcome Measures
BOWEL-DISEASE
Life Style
LONG-TERM INTAKE
FOOD FREQUENCY QUESTIONNAIRE
Inflammation
Tumor Necrosis Factor-alpha
business.industry
Inflammatory Bowel Diseases
medicine.disease
Comorbidity
Diet
RHEUMATOID-ARTHRITIS
Red Meat
Chronic Disease
Quality of Life
treatment outcome
western style diet
business
Zdroj: Christensen, R, Heitmann, B L, Andersen, K W, Nielsen, O H, Sørensen, S B, Jawhara, M, Bygum, A, Hvid, L, Grauslund, J, Wied, J, Glerup, H, Fredberg, U, Villadsen, J A, Kjær, S G, Fallingborg, J, Moghadd, S A G R, Knudsen, T, Brodersen, J, Frøjk, J, Dahlerup, J F, Bojesen, A B, Sorensen, G L, Thiel, S, Færgeman, N J, Brandslund, I, Bennike, T B, Stensballe, A, Schmidt, E B, Franke, A, Ellinghaus, D, Rosenstiel, P, Raes, J, Boye, M, Werner, L, Nielsen, C L, Munk, H L, Nexøe, A B, Ellingsen, T, Holmskov, U, Kjeldsen, J & Andersen, V 2018, ' Impact of red and processed meat and fibre intake on treatment outcomes among patients with chronic inflammatory diseases : protocol for a prospective cohort study of prognostic factors and personalised medicine ', BMJ Open, vol. 8, no. 2, e018166 . https://doi.org/10.1136/bmjopen-2017-018166
Christensen, R, Heitmann, B L, Andersen, K W, Nielsen, O H, Sørensen, S B, Jawhara, M, Bygum, A, Hvid, L, Grauslund, J, Wied, J, Glerup, H, Fredberg, U, Villadsen, J A, Kjær, S G, Fallingborg, J, Moghadd, S A G R, Knudsen, T, Brodersen, J, Frøjk, J, Dahlerup, J F, Bojesen, A B, Sorensen, G L, Thiel, S, Færgeman, N J, Brandslund, I, Bennike, T B, Stensballe, A, Schmidt, E B, Franke, A, Ellinghaus, D, Rosenstiel, P, Raes, J, Boye, M, Werner, L, Nielsen, C L, Munk, H L, Nexøe, A B, Ellingsen, T, Holmskov, U, Kjeldsen, J & Andersen, V 2018, ' Impact of red and processed meat and fibre intake on treatment outcomes among patients with chronic inflammatory diseases : protocol for a prospective cohort study of prognostic factors and personalised medicine ', B M J Open, vol. 8, no. 2, e018166 . https://doi.org/10.1136/bmjopen-2017-018166
BMJ Open
Christensen, R, Heitmann, B L, Andersen, K W, Nielsen, O H, Sørensen, S B, Jawhara, M, Bygum, A, Hvid, L, Grauslund, J, Wied, J, Glerup, H, Fredberg, U, Villadsen, J A, Kjær, S G, Fallingborg, J, Moghadd, S A G R, Knudsen, T, Brodersen, J, Frøjk, J, Dahlerup, J F, Bojesen, A B, Sørensen, G L, Thiel, S, Færgeman, N J, Brandslund, I, Bennike, T B, Stensballe, A, Schmidt, E B, Franke, A, Ellinghaus, D, Rosenstiel, P, Raes, J, Boye, M, Werner, L, Nielsen, C L, Munk, H L, Nexoe, A B, Ellingsen, T, Holmskov, U, Kjeldsen, J & Andersen, V 2018, ' Impact of red and processed meat and fibre intake on treatment outcomes among patients with chronic inflammatory diseases : protocol for a prospective cohort study of prognostic factors and personalised medicine ', BMJ Open, vol. 8, no. 2, :e018166 . https://doi.org/10.1136/bmjopen-2017-018166
Popis: IntroductionChronic inflammatory diseases (CIDs) are frequently treated with biological medications, specifically tumour necrosis factor inhibitors (TNFi)). These medications inhibit the pro-inflammatory molecule TNF alpha, which has been strongly implicated in the aetiology of these diseases. Up to one-third of patients do not, however, respond to biologics, and lifestyle factors are assumed to affect treatment outcomes. Little is known about the effects of dietary lifestyle as a prognostic factor that may enable personalised medicine. The primary outcome of this multidisciplinary collaborative study will be to identify dietary lifestyle factors that support optimal treatment outcomes.Methods and analysisThis prospective cohort study will enrol 320 patients with CID who are prescribed a TNFi between June 2017 and March 2019. Included among the patients with CID will be patients with inflammatory bowel disease (Crohn’s disease and ulcerative colitis), rheumatic disorders (rheumatoid arthritis, axial spondyloarthritis, psoriatic arthritis), inflammatory skin diseases (psoriasis, hidradenitis suppurativa) and non-infectious uveitis. At baseline (pretreatment), patient characteristics will be assessed using patient-reported outcome measures, clinical assessments of disease activity, quality of life and lifestyle, in addition to registry data on comorbidity and concomitant medication(s). In accordance with current Danish standards, follow-up will be conducted 14–16 weeks after treatment initiation. For each disease, evaluation of successful treatment response will be based on established primary and secondary endpoints, including disease-specific core outcome sets. The major outcome of the analyses will be to detect variability in treatment effectiveness between patients with different lifestyle characteristics.Ethics and disseminationThe principle goal of this project is to improve the quality of life of patients suffering from CID by providing evidence to support dietary and other lifestyle recommendations that may improve clinical outcomes. The study is approved by the Ethics Committee (S-20160124) and the Danish Data Protecting Agency (2008-58-035). Study findings will be disseminated through peer-reviewed journals, patient associations and presentations at international conferences.Trial registration numberNCT03173144; Pre-results.
Databáze: OpenAIRE